US Patent 11773174 Anti-IL1RAP antibodies and their use for treating humans
Patent 11773174 was granted and assigned to Cantargia on October, 2023 by the United States Patent and Trademark Office.
Find more entities like US Patent 11773174 Anti-IL1RAP antibodies and their use for treating humans
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
